Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Ophthalmological Medicine
Volume 2012, Article ID 173793, 3 pages
http://dx.doi.org/10.1155/2012/173793
Case Report

Stabilization of Bilateral Progressive Rheumatoid Corneal Melt with Infliximab

1Academic Rheumatology and Osteoporosis Unit, Whipps Cross Hospital, Whipps Cross Road, Leytonstone, London E11 1NR, UK
2Department of Ophthalmology, Whipps Cross Hospital, London E11 1NR, UK

Received 10 February 2012; Accepted 4 April 2012

Academic Editors: C. Giusti and C. G. Kiss

Copyright © 2012 Sheelah F. Antao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Shiuey and C. S. Foster, “Peripheral ulcerative keratitis and collagen vascular disease,” International Ophthalmology Clinics, vol. 38, no. 1, pp. 21–32, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. J. W. Thomas and S. C. Pflugfelder, “Therapy of progressive rheumatoid arthritis-associated corneal ulceration with infliximab,” Cornea, vol. 24, no. 6, pp. 742–744, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Fontana, G. Parente, P. Neri, M. Reta, and G. Tassinari, “Favourable response to infliximab in a case of bilateral refractory Mooren's ulcer,” Clinical and Experimental Ophthalmology, vol. 35, no. 9, pp. 871–873, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Q. Li, B. L. Lokeshwar, A. Solomon, D. Monroy, Z. Ji, and S. C. Pflugfelder, “Regulation of MMP-9 production by human corneal epithelial cells,” Experimental Eye Research, vol. 73, no. 4, pp. 449–459, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. V. A. Smith, H. B. Hoh, and D. L. Easty, “Role of ocular matrix metalloproteinases in peripheral ulcerative keratitis,” British Journal of Ophthalmology, vol. 83, no. 12, pp. 1376–1383, 1999. View at Google Scholar · View at Scopus
  6. S. Chotikavanich, C. S. de Paiva, D. Q. Li et al., “Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome,” Investigative Ophthalmology and Visual Science, vol. 50, no. 7, pp. 3203–3209, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Tracey, L. Klareskog, E. H. Sasso, J. G. Salfeld, and P. P. Tak, “Tumor necrosis factor antagonist mechanisms of action: a comprehensive review,” Pharmacology and Therapeutics, vol. 117, no. 2, pp. 244–279, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Galor, V. L. Perez, J. P. Hammel, and C. Y. Lowder, “Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation,” Ophthalmology, vol. 113, no. 12, pp. 2317–2323, 2006. View at Publisher · View at Google Scholar · View at Scopus